Study details
Enrolling now
tPBM in Older Adults With Traumatic Brain Injury
NYU Langone Health
NCT IDNCT06956404ClinicalTrials.gov data as of Apr 2026
Target enrollment
70
Study length
about 3.2 years
Ages
55–85
Locations
1 site in NY
What this study is about
Researchers are testing a device called transcranial photobiomodulator (tPBM) to see if it helps older adults with traumatic brain injury. The trial will examine how tPBM affects blood flow and executive function.
Simplified from trial records by PatientMatch.
What you may be asked to do
- 1.Use Transcranial photobiomodulator (tPBM)
- 2.Use Transcranial photobiomodulator (tPBM) in sham mode
Participation Burden
What's physically and logistically required of participants.
Logistics & Travel
In-person visits
Requires travel to a study site
Physical Intervention
Standard
How treatment is administered
Treatment Assignment
Randomized & Blinded
You may get a placebo/standard care, and you won't know which.
Extracted study details
Pulled from the trial record to show what is being tested and what the study is measuring.
Endpoints
Secondary: Change in number of treatment emergent adverse events as measured by the Systematic Assessment for Treatment Emergent Effects-Systematic Inquiry (SAFTEE-SI)
Devices
therapeutic